Cover storyContinued Process Verification In Pharma: What Literature Shows
CPV theory is well understood, but literature shows execution is uneven, here's what real-world data reveals about running Stage 3 well.
Cover storyCPV theory is well understood, but literature shows execution is uneven, here's what real-world data reveals about running Stage 3 well.

FDA confirms hidden sildenafil in ZUBB weight-loss supplement intercepted via international mail, raising incoming-material control concerns for QA teams.

Tarsus Pharmaceuticals closes Alkeus acquisition, adding FDA Breakthrough-designated ALK-001 for Stargardt disease to its Phase 3 pipeline.

S&P upgrades Teva to BBB-, completing investment-grade ratings from all three major agencies and signalling durable generics stabilisation.

CBER's consolidated resource hub covers BLA submissions, 21 CFR 600–680 compliance, and postmarketing obligations for biologics manufacturers.
Latest edition

Sep 28
Feb 03From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
